Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells

Read full text
Authors: Lei Zhang, Rahagir Salekeen, Carolina Soto-Palma, Osama Elsallabi, Hongping Ye, Brian Hughes, Borui Zhang, Allancer Nunes, Kyoo-A Lee, Wandi Xu, Abdalla D. Mohamed, Ellie Piepgras
+6 more Sara J. McGowan, Luise Angelini, Ryan O’Kelly, Xianlin Han, Laura J. Niedernhofer, Paul D. Robbins
Cited by: 5
References: 59

Abstract

Cellular senescence is a key driver of the aging process and contributes to tissue dysfunction and age-related pathologies. Senolytics have emerged as a promising therapeutic intervention to extend healthspan and treat age-related diseases. Through a senescent-cell-based phenotypic screen, we identified conjugated polyunsaturated fatty acids (PUFAs), specifically α-eleostearic acid and its methyl ester derivative, as senolytics that effectively killed a broad range of senescent cells, reduced tissue senescence, and extended healthspan in mice. Importantly, these lipids induced senolysis through ferroptosis, rather than apoptosis or necrosis, by exploiting elevated iron, cytosolic PUFAs, and reactive oxygen species (ROS) levels in senescent cells. Mechanistic studies further revealed their key targets in the ferroptosis pathway, ACSL4, LPCAT3, and ALOX15, important for lipid-induced senolysis. These findings identify conjugated PUFAs as ferroptosis-inducing senolytics and establish ferroptosis as a targetable vulnerability of senescent cells.

Fields of Study & Subjects

Telomeres Telomerase and Senescence Ferroptosis and cancer prognosis Retinoids in leukemia and cellular processes

Publication details

Journal / source
Cell Press Blue
Publisher
Elsevier BV
Volume
1
Issue
1
Pages
100004–100004
Publication date
26 February 2026
Language
EN